Literature DB >> 22154486

Efficacy of temporal lobe surgery for epilepsy in patients with negative MRI for mesial temporal lobe sclerosis.

Fernando L Vale1, Euclides Effio, Nicolas Arredondo, Ali Bozorg, Kondi Wong, Carlos Martinez, Katheryne Downes, William O Tatum, Selim R Benbadis.   

Abstract

Epilepsy surgery is a successful treatment for refractory temporal lobe epilepsy (TLE). Reports suggest fewer seizure-free outcomes for patients with TLE and who have a negative brain MRI (nMRI) for mesial temporal sclerosis. Data were collected prospectively from patients with nMRI who underwent temporal lobe surgery for TLE characterized by unilateral ictal temporal lobe seizure onset based on a scalp video electroencephalogram or invasive subdural electrode recordings. A total of 86 patients were followed for at least 24 months after surgery. Outcome was evaluated using the Engel classification. Seizure control was obtained by 55% (47/86) of patients (Class [CL]-I), 27% (23/86) showed significant improvement (CL-II) and 19% (16/86) were deemed surgical failures. Shorter duration of epilepsy, later onset of seizures, and ictal theta rhythm (5-7 Hz) were the most significant predictors of postoperative seizure control. Although hypometabolism on positron emission tomography scan and significant memory disparity (>2.5/8) were not significant prognosticators independently, cumulatively they were predictors for favorable outcome.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22154486     DOI: 10.1016/j.jocn.2011.08.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Interictal scalp electroencephalography and intraoperative electrocorticography in magnetic resonance imaging-negative temporal lobe epilepsy surgery.

Authors:  David B Burkholder; Vlastimil Sulc; E Matthew Hoffman; Gregory D Cascino; Jeffrey W Britton; Elson L So; W Richard Marsh; Fredric B Meyer; Jamie J Van Gompel; Caterina Giannini; C Thomas Wass; Robert E Watson; Gregory A Worrell
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

2.  Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics.

Authors:  Arife Çimen Atalar; Ebru Nur Vanlı-Yavuz; Ebru Yılmaz; Nerses Bebek; Betül Baykan
Journal:  J Neurol       Date:  2019-12-02       Impact factor: 4.849

3.  The patient had a normal magnetic resonance imaging and temporal lobe epilepsy secondary to a porencephalic cyst but showed structural lesions (hippocampal sclerosis).

Authors:  Teppei Matsubara; Satoshi Ayuzawa; Tsukasa Aoki; Ayataka Fujiomto; Satoru Osuka; Akira Matsumura
Journal:  Epilepsy Behav Case Rep       Date:  2013-09-28

4.  Seizure outcomes of temporal lobe epilepsy surgery in patients with normal MRI and without specific histopathology.

Authors:  Jugoslav Ivanovic; Pål G Larsson; Ylva Østby; John Hald; Bård K Krossnes; Jan G Fjeld; Are H Pripp; Kristin Å Alfstad; Arild Egge; Milo Stanisic
Journal:  Acta Neurochir (Wien)       Date:  2017-03-09       Impact factor: 2.216

5.  Neuropsychology Outcomes Following Trephine Epilepsy Surgery: The Inferior Temporal Gyrus Approach for Amygdalohippocampectomy in Medically Refractory Mesial Temporal Lobe Epilepsy.

Authors:  Mike R Schoenberg; William E Clifton; Ryan W Sever; Fernando L Vale
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

6.  Seizure Freedom After Epilepsy Surgery and Higher Baseline Cognition May Be Associated With a Negatively Correlated Epilepsy Network in Temporal Lobe Epilepsy.

Authors:  Elliot G Neal; Mike R Schoenberg; Stephanie Maciver; Yarema B Bezchlibnyk; Fernando L Vale
Journal:  Front Neurosci       Date:  2021-01-18       Impact factor: 4.677

7.  Identification and Validation of a Dysregulated miRNA-Associated mRNA Network in Temporal Lobe Epilepsy.

Authors:  Xing Li; Yunli Han; Dejun Li; Hai Yuan; Shiqin Huang; Xiaolan Chen; Yuanhan Qin
Journal:  Biomed Res Int       Date:  2021-10-22       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.